Tomasz Kubiatowski

2.4k total citations
40 papers, 298 citations indexed

About

Tomasz Kubiatowski is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomasz Kubiatowski has authored 40 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomasz Kubiatowski's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (8 papers) and Melanoma and MAPK Pathways (6 papers). Tomasz Kubiatowski is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (8 papers) and Melanoma and MAPK Pathways (6 papers). Tomasz Kubiatowski collaborates with scholars based in Poland, Hungary and United States. Tomasz Kubiatowski's co-authors include Elżbieta Starosławska, Mahesh B. Lachyankar, Rebecca Salmonsen, Alonzo H. Ross, Lawrence D. Recht, N. Scott Litofsky, Peter J. Quesenberry, Taichang Jang, Iwona Bojar and Marta Makara‐Studzińska and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of neurosurgery.

In The Last Decade

Tomasz Kubiatowski

35 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Kubiatowski Poland 8 169 86 68 42 38 40 298
Lynn M. Neilson United States 10 195 1.2× 173 2.0× 29 0.4× 65 1.5× 27 0.7× 25 389
L. Leopold United States 11 207 1.2× 167 1.9× 162 2.4× 44 1.0× 55 1.4× 27 445
Melanie Seal Canada 9 202 1.2× 132 1.5× 96 1.4× 135 3.2× 35 0.9× 25 447
Janine Lombard Australia 11 204 1.2× 88 1.0× 64 0.9× 78 1.9× 42 1.1× 38 395
Beate Rautenberg Germany 7 230 1.4× 63 0.7× 38 0.6× 42 1.0× 87 2.3× 19 345
Kai‐Bin Yang China 10 141 0.8× 142 1.7× 61 0.9× 61 1.5× 38 1.0× 20 400
Anita Turk United States 9 193 1.1× 161 1.9× 65 1.0× 55 1.3× 33 0.9× 40 356
Janine M. Buonato United States 8 141 0.8× 203 2.4× 56 0.8× 64 1.5× 36 0.9× 10 322
Constanza Maximiano Spain 10 232 1.4× 221 2.6× 72 1.1× 96 2.3× 18 0.5× 30 432
Dagmar Walter Germany 10 81 0.5× 148 1.7× 94 1.4× 36 0.9× 31 0.8× 11 315

Countries citing papers authored by Tomasz Kubiatowski

Since Specialization
Citations

This map shows the geographic impact of Tomasz Kubiatowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Kubiatowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Kubiatowski more than expected).

Fields of papers citing papers by Tomasz Kubiatowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Kubiatowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Kubiatowski. The network helps show where Tomasz Kubiatowski may publish in the future.

Co-authorship network of co-authors of Tomasz Kubiatowski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Kubiatowski. A scholar is included among the top collaborators of Tomasz Kubiatowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Kubiatowski. Tomasz Kubiatowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubiatowski, Tomasz & Ewa Kalinka‐Warzocha. (2025). Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer. Menopausal Review. 24(3). 206–210.
2.
Kowalik, Artur, et al.. (2024). Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement. Oncology in Clinical Practice. 20(4). 229–244. 2 indexed citations
3.
Radecka, Barbara, et al.. (2023). Immunotherapy for colorectal cancer. Oncology in Clinical Practice. 19(3). 133–139.
4.
Cybulska-Stopa, Bożena, Marcin Ziętek, Łukasz Galus, et al.. (2023). Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma. Targeted Oncology. 18(2). 235–245. 2 indexed citations
5.
Cybulska-Stopa, Bożena, Anna M. Czarnecka, Marcin Ziętek, et al.. (2023). 1115P Comparison of efficacy and toxicity of dabrafenib/trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice. Annals of Oncology. 34. S672–S672. 2 indexed citations
6.
Radecka, Barbara, et al.. (2023). Immunotherapy for gastroesophageal cancer. Oncology in Clinical Practice. 19(3). 140–150. 1 indexed citations
7.
8.
Cybulska-Stopa, Bożena, Łukasz Galus, Marcin Ziętek, et al.. (2023). Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment. Melanoma Research. 33(3). 208–217. 7 indexed citations
9.
Czarnecka, Anna M., Bożena Cybulska-Stopa, Marcin Ziętek, et al.. (2022). Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers. 14(9). 2123–2123. 5 indexed citations
10.
Cybulska-Stopa, Bożena, Marcin Ziętek, Anna M. Czarnecka, et al.. (2021). Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. Journal of Dermatological Treatment. 33(4). 2168–2174. 8 indexed citations
11.
Cybulska-Stopa, Bożena, Marcin Ziętek, Anna M. Czarnecka, et al.. (2021). Comparison of the efficacy and toxicity of anti-PD-1 monoclonal antibodies (nivolumab versus pembrolizumab) in treatment of patients with metastatic melanoma.. Journal of Clinical Oncology. 39(15_suppl). e21514–e21514. 2 indexed citations
12.
Cybulska-Stopa, Bożena, Renata Pacholczak‐Madej, Grażyna Kamińska‐Winciorek, et al.. (2020). First-Line Treatment of Advanced/Metastatic Melanoma with Anti-PD-1 Antibodies: Multicenter Experience in Poland. Immunotherapy. 13(4). 297–307. 10 indexed citations
13.
Wojas‐Krawczyk, Kamila & Tomasz Kubiatowski. (2020). Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research. Frontiers in Oncology. 10. 568174–568174. 10 indexed citations
14.
Cybulska-Stopa, Bożena, Marcin Ziętek, Grażyna Kamińska‐Winciorek, et al.. (2020). Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients. Melanoma Research. 31(1). 49–57. 5 indexed citations
15.
Cybulska-Stopa, Bożena, Anna M. Czarnecka, Łukasz Galus, et al.. (2020). BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma. Melanoma Research. 30(5). 465–471. 15 indexed citations
16.
Burdan, Franciszek, Robert Klepacz, Jerzy Walocha, et al.. (2017). Place of residence does not significantly influence radiological morphology of cervical cancer. Annals of Agricultural and Environmental Medicine. 24(3). 527–531. 1 indexed citations
17.
Kamińska, Marzena, Tomasz Ciszewski, Bożena Kukiełka-Budny, et al.. (2015). Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy. Annals of Agricultural and Environmental Medicine. 22(4). 724–730. 32 indexed citations
18.
Futyma, Konrad, et al.. (2010). Maspina: nowy cel terapii przeciwnowotworowej. Nowotwory Journal of Oncology. 60(1). 50–50.
19.
Duchnowska, Renata, Rafał Dziadziuszko, Bogumiła Czartoryska-Arłukowicz, et al.. (2009). Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Research and Treatment. 117(2). 297–303. 44 indexed citations
20.
Filip, Agata, et al.. (2009). The Outgrowth of CLL Nurselike Cells in Vitro, and Its Relation to Clinical and Hematological Parameters.. Blood. 114(22). 2360–2360. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynn M. Neilson Breakdown of academic impact, for papers by L. Leopold Breakdown of academic impact, for papers by Melanie Seal Breakdown of academic impact, for papers by Janine Lombard Breakdown of academic impact, for papers by Beate Rautenberg Breakdown of academic impact, for papers by Kai‐Bin Yang Breakdown of academic impact, for papers by Anita Turk Breakdown of academic impact, for papers by Janine M. Buonato Breakdown of academic impact, for papers by Constanza Maximiano Breakdown of academic impact, for papers by Dagmar Walter
Rankless by CCL
2026